INTRODUCTION
In the pathogenesis of obesity-associated type 2 diabetes, chronic exposure to elevated blood glucose concentrations (glucotoxicity) and excess levels of circulating lipids (lipotoxicity) promote progressive failure and death of the insulinsecreting pancreatic β-cells (1) (2) (3) . Moreover, the combined excess of glucose and lipids (glucolipotoxicity) may synergize to cause a faster and more severe progression of β-cell demise (4, 5) . Endoplasmic reticulum (ER) stress contributes to the loss of functional β-cells (1, (6) (7) (8) . ER stress activates the unfolded protein response (UPR), an adaptive measure initially aimed at restoring homeostasis through down-regulation of general protein translation and up-regulation of select genes encoding molecular chaperones and the machinery for ER associated degradation of proteins (ERAD). If the UPR fails to mitigate ER stress, a transition occurs whereby the UPR instead promotes apoptosis (9) . While the involvement of ER stress in glucose-and lipid-induced β-cell pathobiology is widely accepted, many details regarding the regulation of the β-cell UPR, and its mechanistic links to β-cell death, remain unclear.
Chronic cellular stress triggers cell death by intrinsic apoptosis, which is regulated by proteins in the Bcl-2 family (10) . Mitochondrial outer membrane permeabilization, a critical step in this process, is carried out by the pro-apoptotic family members Bax and Bak (11, 12) . Combined deletion of Bax and Bak thus provides a powerful means of dissecting the involvement of the canonical intrinsic apoptosis pathway. Unrelieved ER stress has also been demonstrated to trigger Bax and Bakdependent death of several cell types (11, (13) (14) (15) . However, most studies of Bax and Bak in primary pancreatic β-cells under ER stress, including in human type 2 diabetes, have been correlative reports of increased expression or mitochondrial translocation of Bax (8, 16, 17) . The few loss-offunction studies that have specifically addressed their requirement for β-cell apoptosis suggest that loss of either protein alone provides partial protection from cytokine-induced death (18) , and that Bax -/β-cells show a modest protection from glucolipotoxicity (19) . This could reflect significant overlap in signaling β-cell apoptosis, not unlike their redundant roles in cell death during development (20) . However, apoptosis induced by chronic glucotoxicity or Pdx1 deficiency appears to preferentially engage Bax (21, 22) . This indicates that the relative involvement of the two proteins may be context-and stress-specific, but to date no study has included a full comparison of the individual and combined contributions of both Bax and Bak to stress-induced death in primary β-cells.
A growing body of work is also uncovering physiological functions of various Bcl family apoptosis proteins (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . We recently reported that anti-apoptotic Bcl-2 and Bcl-x L modulate βcell mitochondrial metabolism, glucose responsiveness, and ROS signaling (30, 31) . Others have shown that glucokinase activity is controlled by pro-apoptotic Bad (26, 27) . Studies in non-βcells have implicated both Bax and Bak in ER physiology and UPR signaling (13, 28) , and Bax in the regulation of mitochondrial bioenergetics (29) . It therefore remains an important question if Bax and Bak have non-apoptotic functions in pancreatic β-cells.
In this study we established lines of inducible knockout mice to determine the effects of single and combined Bax-Bak deficiency on β-cell function, ER stress signaling, and survival. We provide the first direct molecular assessment of the requirement for the intrinsic, mitochondrial, apoptosis pathway in glucolipotoxic β-cell death. Moreover, our data reveal that Bax and Bak do not play significant roles in β-cell function, but dampen the UPR in pancreatic islets during the early stages of ER stress.
EXPERIMENTAL PROCEDURES Mice and in vivo studies
To establish the 4 genotypes of mice used for these studies we first bred Bax flox/flox :Bak -/mice (Stock number 006329, The Jackson Laboratory) with Pdx1-CreER mice (33) to create littermate mice with Bak single knockout (Bak SKO; Bax flox/flox :Bak -/-) and Bax-Bak double knockout (Bax-Bak DKO; Bax flox/flox :Bak -/-:Pdx1-CreER + ) (34, 35) . We further mated Bax flox/flox :Bak +/progeny to re-introduce the wild-type Bak allele and obtain a parallel colony of Bax single knockout (Bax SKO; Bax flox/flox :Bak +/+ :Pdx1-CreER + ) and littermate wild-type mice (WT; Bax flox/flox :Bak +/+ ). Whenever possible, littermates were compared (Bak SKO vs Bax-Bak DKO, and Bax SKO vs WT). In all other instances age-and sex-matched mice from the two parallel lines were used. To induce Bax gene deletion, tamoxifen (3 mg/40 g body weight) was administered daily by intraperitoneal (ip) injection for 4 consecutive days. All mice, including controls, were similarly injected by tamoxifen. In vivo glucose tolerance was assessed by ip glucose tolerance tests after a 6 h fast. Glucose (2 g/kg body weight) was administered by ip injection and tail vein blood droplets were read using OneTouch Ultra Blue Test Strips (Lifescan) at the indicated time points. To minimize any putative long-term effects of Bax-Bak deletion, all in vivo experiments and islet isolations were done no later than 14 days following the final tamoxifen injection. The animal studies were approved by the University of British Columbia Animal Care Committee.
Pancreatic islet isolation, dispersion, and culture
Mouse pancreatic islets were isolated from 12-16 week old mice by collagenase digestion followed by filtration-based purification, as previously described (30). Isolated islets were hand-picked and cultured overnight before further treatment. Palmitic acid was prepared in a 6:1 ratio with bovine serum albumin, as detailed previously (1) . Unless otherwise indicated, islets were cultured in RPMI 1640 completed with 2% penicillinstreptomycin and 10% fetal bovine serum (Gibco, Thermo Fisher). For single-cell analyses, islets were dispersed into single cells prior to study, as described (36).
Fluorescence Microscopy
Glucose-induced changes in cytosolic Ca 2+ were compared in cultured intact islets using the ratiometric fluorescent Ca 2+ indicator fura-2, as described (36). For measurements of mitochondrial membrane potential, dispersed islet cells were loaded for 30 minutes with 50 nM of the fluorescent indicator tetramethylrhodamine ethyl ester perchlorate (TMRE). Loading and imaging was done in phenol red-free RPMI 1640 and differences in mitochondrial membrane potential quantified by the absolute TMRE fluorescence intensity collected using a 585/60m emission filter following excitation using a 530/20x filter (Chroma Technology, Bellows Falls, VT, USA).
Islet insulin secretion and content
For static assays of glucose-stimulated insulin secretion size-matched islets were first preincubated for 1 hour in Krebs-Ringer Buffer (KRB; 129 mM NaCl, 4.8 mM KCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 5 mM NaHCO 3 , 10 mM HEPES, 0.5% bovine serum albumin) containing 3 mM glucose. The islets were then incubated in KRB with 3 mM glucose and then 20 mM glucose for 1 hour each, followed by 30 min incubation with KRB containing 3 mM glucose + 30 mM KCl. Supernatant was collected after each stimulation and assayed for secreted insulin. For quantification of insulin content, size-matched islets were washed twice with 1xPBS, collected in a 0.1 M HCl/70% ethanol solution and sonicated. Secreted insulin and insulin content were measured by radioimmunoassay (Rat insulin RIA Kit, Cedarlane, Burlington, ON, CA) or using the Mouse Ultrasensitive Insulin ELISA kit (ALPCO, Salem, NH, USA).
Cell death assays
For quantification of cell death, dispersed islet cells were seeded into 96-well plates (Perkin Elmer ViewPlates) and allowed to adhere for 48 hours in complete media. As previously detailed (30), the cultures were stained with Propidium Iodide (0.5 g/ml) and Hoechst 33342 (0.05 g/ml) for 30 min before exposure to the indicated stress or control conditions. The 96-well plates were placed in an environmentally controlled (37°C, 5% CO 2 ) ImageXpress Micro high content screening system (Molecular Devices) for the duration of imaging. Subsequently, cell death was determined as the number of PI positive cells relative to the number of Hoechst 33342 positive cells using the MetaXpress software (Molecular Devices, San Jose, CA, USA).
Real-time PCR analysis of islet mRNA
Total islet mRNA was extracted using the RNEasy Mini Kit (Qiagen) and cDNA was synthesized by reverse transcription using 100 ng RNA and the qScript cDNA synthesis kit (Quanta Biosciences). Target gene expression was measured relative to mouse -Actin housekeeping gene using PerfeCTa SYBR Green SuperMix plus ROX (Quanta Biosciences) and assayed using Applied Biosystems StepOnePlus and Applied Biosystems 7500Fast Real-Time qPCR machines. Primers were synthesized from IDT (Table 1) .
Reagents and compounds
InSolution Staurosporine was from Calbiochem/EMD Millipore. Dimethyl Sulfoxide (DMSO), Thapsigargin (Tg), Palmitic Acid (PA), Propidium Iodide (PI), Tetramethylrhodamine Ethyl Ester Perchlorate (TMRE), Collagenase Type XI from clostridium histolyticum, and Tamoxifen (TM) were from Sigma-Aldrich (St. Louis, MO, USA). Fura-2/AM and Hoechst 33342 were from Invitrogen/Life Technologies (Burlington, ON, CA).
Statistical analysis
Data are presented as mean ± SEM. Data analysis was performed using GraphPad Prism 6.0 software. Statistical analysis was performed by student's ttests, 1-way ANOVA, or 2-way ANOVA with Bonferroni post-hoc comparisons where appropriate.
Differences were considered significant if p < 0.05.
RESULTS

Loss of Bax and/or Bak does not affect normal islet function and glucose homeostasis
In mice, combined global knockout of Bax and Bak results in severe developmental abnormalities and perinatal death of most double knockout animals (20) . Tissue-specific gene deletion is therefore required to study the effect of combined Bax and Bak loss. We previously established a line of Bak null mice in which the additional deletion of Bax can be selectively induced in β-cells of the adult animals by tamoxifen administration (30). To allow a comprehensive study of the individual and combined roles of Bax and Bak, we have now expanded this mouse colony to include the four genotypes: Wild-type (WT), Bax single-knockout (Bax SKO), Bak single knockout (Bak SKO), and Bax-Bak double knockout (Bax-Bak DKO) (cf. Experimental Procedures). Using real-time PCR we confirmed the complete absence of Bak mRNA, as well as the expected >80% knockdown of Bax in islets from all mice carrying the floxed Bax alleles following tamoxifen administration ( Fig. 1 ). We previously demonstrated that the decreases in Bax and Bak mRNA are associated with similarly reduced islet protein (30).
Comparison of male and female mice of all four genotypes showed that single and double knockout mice all had normal body weights. Intraperitoenal glucose tolerance tests further demonstrated that there were no differences in the glucose tolerance of mice of all genotypes (Fig. 2) . To more directly examine the impact of Bax-Bak deletion on β-cell function, we measured cytosolic Ca 2+ responses and insulin secretion in isolated islets. No differences were observed in the cytosolic Ca 2+ levels of WT and Bax-Bak DKO islets under basal conditions, or in the response to a stepwise glucose increase or direct depolarization with KCl ( Fig. 3A,B ). Double knockout of Bax and Bak did not affect islet insulin secretion under basal or acute glucose-stimulated conditions (Fig. 3C ), and both islet insulin mRNA levels and insulin content did not differ between WT and Bax-Bak DKO islets in normal culture ( Fig. 3D ,E). Single deletion of Bax or Bak also did not affect islet function (data not shown). These results demonstrate that individual or combined loss of Bax and/or Bak in the adult βcell has no detectable effects on the function of pancreatic islets under normal, non-stressed, conditions. Further, our comparison of the four different genotypes allows us to conclude that the life-long loss of Bak in all tissues does not affect in vivo glucose homeostasis.
Single and double Bax/Bak deletion reveals nonredundant roles in STS-induced β-cell apoptosis
To investigate the relative importance of Bax and Bak in executing β-cell apoptosis, we first performed a detailed kinetic analysis of staurosporine (STS)-induced death. STS is a pankinase inhibitor that has been demonstrated to activate Bcl-2-sensitive, Bax-Bak-dependent, apoptosis (11, 37) . Analysis of STS-induced death in islet cells of all four genotypes showed that WT cell death was initiated after roughly 12 hours and reached a maximal plateau by 36 hours (Fig. 4A ). Absence of Bax and/or Bak markedly prevented cell death, with their combined deletion providing the highest degree of protection ( Fig. 4A,B) . Overall, the onset of STS-induced death of Bax SKO islet cells was delayed by several hours and then progressed at a significantly reduced rate. No death of Bak SKO and Bax-Bak DKO cells was detected until after more than 24 hours of STSinduced stress. That Bax SKO islet cells were less protected than those from Bak null mice likely reflects death of non-β islet cells that do not express Cre and therefore still have Bax. Consistent with loss of mitochondrial integrity in STS-induced apoptosis, WT islet cells showed a significant reduction in mitochondrial membrane potential after 24 hours. In contrast, the mitochondrial polarization of Bax-Bak DKO β-cells did not change, further supporting that mitochondrial outer membrane permeabilization was blocked at this time-point ( Fig. 4C) . Notably, islet cell death reached similar levels in all genotypes after approximately 48 hours of exposure to STS (Fig.  4A ), indicating the activation of late-stage β-cell death that proceeds independently of the canonical machinery for intrinsic apoptosis.
Together, these findings demonstrate that the combined functions of Bax and Bak are required for STS-induced apoptosis in pancreatic β-cells, revealing that they cannot compensate for each other in this context. Further, our results show that chronic in vitro β-cell stress can eventually activate alternate, non-apoptotic, death mechanisms.
Combined deletion of Bax and Bak is required for protection, and reveals multiple β-cell death modes, under glucolipotoxic stress
We next examined the requirement for Bax and Bak in mediating β-cell death during the diabetes-relevant conditions of glucose-and lipidinduced stress. Dispersed β-cells were cultured for up to 58 hours in the presence of varying levels of glucose with or without addition of the free fatty acid palmitate. Culture in low glucose (5 mM), high glucose (25 mM), or under strong lipotoxic conditions alone (5 mM glucose with 1.5 mM palmitate in 6:1 ratio with BSA), did not result in detectable death of islet cells from WT, Bak SKO, Bax SKO, or Bax-Bak DKO mice ( Fig. 5 and data not shown). In contrast, glucolipotoxic stress caused progressive death of islet cells of all four genotypes (Fig. 5 ). Only the combined knockout of Bax and Bak provided significant protection against the glucolipotoxic insult, and this protection did not manifest until later stages of the experiment (Fig.  5A,B) . Close inspection of the kinetic profile revealed a notable inflection point specifically in the death curve of Bax-Bak DKO cells at approximately 32 hours. Quantitation of the slope during 14 hour intervals before and after this timepoint confirmed that the rate of death of WT and Bax-Bak DKO islet cells was similar at first, but then decreased significantly in the Bax-Bak DKO cells only (Fig. 5C ). This suggests a time-dependent switch from predominantly non-apoptotic β-cell death toward Bax-and Bak-mediated apoptosis during chronic glucolipotoxic stress. Intriguingly, the comparison of all four genotypes further suggests that Bax and Bak are functionally redundant in signaling this late-stage β-cell apoptosis, which is in contrast to their combined requirement for STS-induced apoptosis.
Bax and Bak suppress the early unfolded protein response in β-cells under ER stress
Chronic hyperglycemia and elevated free fatty acids disrupt ER homeostasis and trigger ER stress, which contributes to β-cell dysfunction and death in diabetes pathogenesis. Motivated by evidence for involvement of Bcl-2 family proteins in the control of ER physiology (13,28), we next investigated whether Bax and Bak have roles in regulating β-cell UPR signaling under glucolipotoxic conditions. During ER stress, the expression of CHOP and XBP1s increases as a result of PERK and IRE1α activation, respectively. Under normal culture conditions WT and Bax-Bak DKO islets had similar expression levels of both CHOP and XBP1s (data not shown), indicating that Bax and Bak are not required for maintenance of basal β-cell ER homeostasis. Relative to culture in high glucose alone, the combination of high glucose and palmitate time-dependently increased CHOP and XBP1s mRNA in islets of all 4 genotypes (Fig.  6A,B and data not shown). Compared to WT, XBP1s transcripts were induced at significantly higher levels in Bax-Bak DKO islets after 24 hours, but this difference evened out by 48 hours (Fig.  6A) . A trend toward higher CHOP mRNA was also seen in DKO islets after 48 hours, but this did not reach statistical significance (Fig. 6B) . The individual deletion of Bax or Bak did not result in detectable differences compared to WT (data not shown). This suggests that Bax and Bak have redundant roles in dampening UPR signaling in βcells under glucolipotoxic stress.
A glucolipotoxic insult activates a multifaceted β-cell response characterized not only by ER stress, but also by oxidative stress and general perturbations in other organelles (5) . We therefore also examined the UPR following more specific ER stress, induced by thapsigargin, a chemical inhibitor of SERCA-mediated ER Ca 2+ uptake (38) . As expected, thapsigargin induced time-dependent expression of CHOP and XBP1s in the islets, with significant increases after just 3 hours (Fig. 6C,D) . Similar to what was seen during glucolipotoxic stress, thapsigargin-mediated induction of XBP1s and CHOP mRNA levels were accelerated as a result of Bax-Bak double deletion, and the difference evened out following more chronic stress. Together, these data show that Bax and Bak dampen earlier stages of β-cell ER stress signaling involving both the IREα and PERK arms of the UPR.
To further assess the impact of combined Bax-Bak deletion on β-cell UPR signaling we examined the time-dependent expression of other UPR genes, including molecular chaperones and downstream target genes involved in the regulation of ER redox status and protein degradation. Thapsigargininduced ER stress increased the expression of all genes examined (Fig. 7) . In no instances did the basal expression of the UPR-related genes differ between islets from WT and Bax-Bak DKO mice, and under no conditions tested were UPR-related transcripts higher in the WT islets. However, in Bax-Bak DKO islets the mRNA levels of IRE1 itself were significantly increased after 6 hours treatment, and at 16 hours the mRNA levels of the chaperone BIP/HSPA5, the ER-associated glycoprotein WFS1 (Wolframin) (39) , and the protein disulfide isomerase PDI-P5, were significantly higher compared to WT islets (Fig. 7) .
These findings demonstrate that Bax and Bak together attenuate the UPR in pancreatic islets, revealing functions in β-cell stress signaling prior to activation of mitochondrial outer membrane permeabilization.
DISCUSSION
In this study we used conditional and inducible gene deletion to dissect the roles of the apoptotic executioner proteins Bax and Bak in pancreatic βcell function, as well as β-cell ER stress and death following combined exposure to high levels of glucose and fatty acids.
Roles of Bax and Bak in the execution of β-cell death under diabetogenic stress -There is compelling evidence that apoptosis contributes to the loss of β-cell mass in human type 2 diabetes (3).
In line with this, Bax mRNA and protein levels are significantly increased in islets from type 2 diabetic patients compared to non-diabetic controls (8, 17) . Islet levels of both Bax and Bak also increase during the progression of type 2 diabetes in the db/db mouse, but not in islets from obese ob/ob mice that remain normoglycemic (40) . This suggests that Bax and Bak actively contribute to the diabetic islet phenotype. Accordingly, in vitro work has demonstrated roles for Bax, Bak, and other Bcl family members in β-cell death during lipotoxic and glucotoxic stress (16,17,21,41,42).
We did not detect β-cell death under culture with high glucose alone, or in response to palmitate in the presence of low glucose. This supports the idea that elevated glucose and lipids together induce a more detrimental 'glucolipotoxic' state (5, 43) . Others have demonstrated that glucotoxic βcell death is Bak-independent, but involves Bax (21), likely via 'upstream' pro-apoptotic BH3-only family members Puma and Bim (12, 17) . This was observed using longer and more severe glucotoxic conditions than those we used here, and does therefore not disagree with our data. Lipotoxicity is known to activate Bax and β-cell apoptosis (1, 16) . The resilience of our primary mouse cells to pure lipotoxicity prevented us from clarifying the role of Bak in lipotoxic β-cell death.
Bax-Bak redundancy characterizes apoptosis during development (20) and also several known instances of pathogenic cell death in vivo, including of motor neurons in amyotrophic lateral sclerosis (44) and hepatocytes under severe ER stress (28) . In this study, we found that primary β-cell death during the compound stress of glucolipotoxicity progressed normally with either Bax or Bak alone, suggesting a similar redundancy. In contrast, STSinduced β-cell apoptosis required the presence of both proteins. In conjunction with other studies that report preferential involvement of Bax in β-cell apoptosis under glucotoxicity (21) and Pdx1 deficiency (22) , this illustrates that the relative requirement for Bax and Bak in β-cell death can depend on the specific form of stress.
Our Bax-Bak double knockout model allowed us to identify both apoptotic and non-apoptotic βcell death during STS treatment and glucolipotoxicity. This agrees with the finding that stressed primary β-cells often die without all the morphological features of apoptosis (45) . Moreover, death of Pdx-1-deficient β-cells happens by apoptosis, as well as necrosis involving the mitochondrial permeability transition pore (mPTP) (46) (47) (48) . In myocardial infarctions deletion of Bax prevents both mPTP-driven necrosis and apoptosis (49) , while loss of Bax in human leukemic CEM cells rather shifts ER stress-induced death from apoptotic to mPTP-dependent mechanisms (50) . We observed late-stage death of STS-treated Bax-Bak DKO β-cells that might reflect an analogous apoptosis-to-necrosis switch. Inversely, our analyses indicated that non-apoptotic mechanisms dominate in the early stages of glucolipotoxic β-cell death. In future studies it will be important to further clarify the molecular nature, and putative crosstalk, of apoptotic and non-apoptotic β-cell loss under various stresses.
Non-apoptotic roles of Bax and Bak in β-cell physiology and stress-signaling -Glucosestimulated insulin release from β-cells depends on mitochondrial oxidative metabolism. A significant pool of cellular Bak is anchored in the outer mitochondrial membrane. In non-apoptotic cells this Bak binds to voltage-dependent anion channel 2, a protein involved in the mitochondrial transport of ions and metabolites (51) . Furthermore, Bax and Bak have both been implicated in the control of normal mitochondrial fusion processes (52, 53) . This all hints that Bax and Bak might affect mitochondrial physiology. Indeed, Bax has been shown to promote mitochondrial bioenergetics in healthy HCT-116 cells and hepatocytes (29) . Under normal culture conditions we observed a modest reduction in the mitochondrial membrane potential of Bax-Bak DKO islet cells, relative to WT. However, we established that this difference did not significantly alter glucose-stimulated Ca 2+ signals and insulin secretion, which is further backed by normal glucose homeostasis in our knockout mice. In contrast, we and others have demonstrated that anti-apoptotic Bcl-2 and Bcl-x L dampen β-cell glucose responses independently of Bax or Bak (30,54). Also, pro-apoptotic Bad modulates insulin secretion via interactions with glucokinase (27) . It thus appears that Bcl-2 family proteins show different degrees of involvement in β-cell mitochondrial physiology.
Pools of Bax and Bak also localize to the ER (14), where they may affect cell survival via ERderived Ca 2+ signals (13, 55) . Previous work by Hetz et al. further found that loss of Bax and Bak impaired IRE1α-dependent UPR signaling in MEFs and hepatocytes (28) . In pancreatic islets we observed the opposite; combined loss of β-cell Bax and Bak moderately amplified the early UPR under glucolipotoxic conditions and following chemical induction of ER stress. Since severe ER stress and chronic UPR signaling trigger β-cell apoptosis, it is possible Bax and Bak oppose their own activation. However, the UPR also serves an adaptive role (40, 56) . It is therefore also possible that Bax and Bak may impair the β-cell's ability for 'glucolipoadaptation', thereby promoting both early dysfunction and late-stage death (43, 57) . Differentiating between these opposing outcomes will require very careful consideration of the timeand context-dependent transition from adaptive to apoptotic β-cell UPR signaling.
In summary, we used mouse models of inducible and conditional gene deletion to dissect the roles of pro-apoptotic Bax and Bak in β-cells. Our findings show that Bax and Bak do no play roles in normal β-cell function. Further, we provide new mechanistic insights into the mechanisms of glucolipotoxic β-cell loss and show for the first time that these pro-apoptotic Bcl-2 family proteins can modulate ER stress signaling in the endocrine pancreas. 
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